JAMA[journal] 检索结果

1001. NIH Caps Indirect Cost Rates.

作者: Gregory Curfman.
来源: JAMA. 2025年333卷21期1858-1859页

1002. The National Institutes of Health Cap on Indirect Rates for Research Institutions-Law and Policy.

作者: Lawrence O Gostin.;Jennifer S Bard.
来源: JAMA. 2025年333卷21期1857-1858页

1003. Biomedical Innovation and Equitable Access-Reply.

作者: Victor J Dzau.;Emily L Shambaugh.;Melissa H Laitner.
来源: JAMA. 2025年333卷19期1731-1732页

1004. Communicating With Patients About Surgery.

作者: Lauren J Taylor.;Emily B Rivet.;Muneera R Kapadia.
来源: JAMA. 2025年333卷21期1920-1921页

1005. Sex-Based Differences in Binge and Heavy Drinking Among US Adults.

作者: Bryant Shuey.;Hefei Wen.;Katie J Suda.;Alyssa Burnett.;James Franklin Wharam.;Timothy S Anderson.;Jane M Liebschutz.
来源: JAMA. 2025年333卷20期1831-1833页

1006. NIH Funding Has Stagnated Since 2003.

作者: Nadir Yehya.
来源: JAMA. 2025年333卷21期1860-1861页

1007. Biomedical Innovation and Equitable Access.

作者: Klaus Lindpaintner.
来源: JAMA. 2025年333卷19期1731页

1008. CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials.

作者: Sally Hopewell.;An-Wen Chan.;Gary S Collins.;Asbjørn Hróbjartsson.;David Moher.;Kenneth F Schulz.;Ruth Tunn.;Rakesh Aggarwal.;Michael Berkwits.;Jesse A Berlin.;Nita Bhandari.;Nancy J Butcher.;Marion K Campbell.;Runcie C W Chidebe.;Diana Elbourne.;Andrew Farmer.;Dean A Fergusson.;Robert M Golub.;Steven N Goodman.;Tammy C Hoffmann.;John P A Ioannidis.;Brennan C Kahan.;Rachel L Knowles.;Sarah E Lamb.;Steff Lewis.;Elizabeth Loder.;Martin Offringa.;Philippe Ravaud.;Dawn P Richards.;Frank W Rockhold.;David L Schriger.;Nandi L Siegfried.;Sophie Staniszewska.;Rod S Taylor.;Lehana Thabane.;David Torgerson.;Sunita Vohra.;Ian R White.;Isabelle Boutron.
来源: JAMA. 2025年333卷22期1998-2005页

Well-designed and properly executed randomized trials are considered the most reliable evidence on the benefits of health care interventions. However, there is overwhelming evidence that the quality of reporting is not optimal. The CONSORT (Consolidated Standards of Reporting Trials) statement was designed to improve the quality of reporting and provides a minimum set of items to be included in a report of a randomized trial. CONSORT was first published in 1996, then updated in 2001 and 2010. Herein, we present the updated CONSORT 2025 statement, which aims to account for recent methodological advancements and feedback from end users.

1009. Are Procalcitonin Measures a Reliable Predictor of Stopping Antibiotics Among Patients With Sepsis?-Reply.

作者: Paul Dark.;Anower Hossain.;Ranjit Lall.
来源: JAMA. 2025年333卷19期1730-1731页

1010. Are Procalcitonin Measures a Reliable Predictor of Stopping Antibiotics Among Patients With Sepsis?

作者: Mattia Arrigo.;Lars C Huber.
来源: JAMA. 2025年333卷19期1729页

1011. Drug Decriminalization in British Columbia and Changes in Drug Crime and Opioid and Stimulant Harms.

作者: Adrienne Gaudreault.;Robert Talarico.;Matthew Herder.;Daniel T Myran.
来源: JAMA. 2025年333卷21期1922-1925页

1012. Use of Life Support and Outcomes Among Patients Admitted to Intensive Care Units.

作者: Emily E Moin.;Nicholas J Seewald.;Scott D Halpern.
来源: JAMA. 2025年333卷20期1793-1803页

Nationwide data are unavailable regarding changes in intensive care unit (ICU) outcomes and use of life support over the past 10 years, limiting understanding of practice changes.

1013. Are Procalcitonin Measures a Reliable Predictor of Stopping Antibiotics Among Patients With Sepsis?

作者: Chi-Kuei Hsu.;Chih-Cheng Lai.
来源: JAMA. 2025年333卷19期1728-1729页

1014. Are Procalcitonin Measures a Reliable Predictor of Stopping Antibiotics Among Patients With Sepsis?

作者: Nicholas A Bosch.;Kevin C Wilson.;Anica C Law.
来源: JAMA. 2025年333卷19期1728页

1015. Why Good Palliative Care Clinicians Get Fired.

作者: Abby R Rosenberg.;Elliot Rabinowitz.;Robert M Arnold.
来源: JAMA. 2025年333卷21期1864-1865页

1016. Are Procalcitonin Measures a Reliable Predictor of Stopping Antibiotics Among Patients With Sepsis?

作者: Xianshi Zhou.;Xiaotu Xi.;Huiyan Zeng.
来源: JAMA. 2025年333卷19期1729-1730页

1017. Cataracts: A Review.

作者: Stephanie P Chen.;Fasika Woreta.;David F Chang.
来源: JAMA. 2025年333卷23期2093-2103页

Age-related cataract, defined as progressive opacification or clouding of the eye's natural lens, is a leading cause of visual disability and blindness. Cataract surgery is one of the most commonly performed procedures in high-income countries. More than 3.5 million cataract operations are performed annually in the US.

1018. Rise in Vaping Keeps Tobacco Use High.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷18期1570页

1019. Clinicians' PTO Undermined by Patient Portal Work, Study Finds.